Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lung Neoplasms | 153 | 2024 | 13381 | 7.350 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 83 | 2024 | 5314 | 5.950 |
Why?
|
Thymus Neoplasms | 8 | 2023 | 274 | 3.110 |
Why?
|
Adenocarcinoma | 41 | 2023 | 6345 | 2.860 |
Why?
|
Immunohistochemistry | 56 | 2022 | 11076 | 2.580 |
Why?
|
High-Throughput Nucleotide Sequencing | 46 | 2024 | 3639 | 2.460 |
Why?
|
Mutation | 95 | 2024 | 30053 | 2.410 |
Why?
|
Testicular Neoplasms | 15 | 2024 | 799 | 2.010 |
Why?
|
Gene Amplification | 7 | 2023 | 1089 | 1.910 |
Why?
|
Gene Rearrangement | 13 | 2024 | 1125 | 1.890 |
Why?
|
Pleural Neoplasms | 5 | 2023 | 609 | 1.880 |
Why?
|
In Situ Hybridization, Fluorescence | 28 | 2024 | 2510 | 1.670 |
Why?
|
DNA Mutational Analysis | 25 | 2024 | 4111 | 1.630 |
Why?
|
Proto-Oncogene Proteins c-met | 12 | 2024 | 571 | 1.610 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 26 | 2023 | 1745 | 1.540 |
Why?
|
Sex Cord-Gonadal Stromal Tumors | 8 | 2024 | 118 | 1.520 |
Why?
|
Small Cell Lung Carcinoma | 6 | 2022 | 423 | 1.450 |
Why?
|
Thymoma | 3 | 2023 | 188 | 1.410 |
Why?
|
DNA, Neoplasm | 6 | 2020 | 1745 | 1.400 |
Why?
|
DNA Mismatch Repair | 7 | 2023 | 428 | 1.320 |
Why?
|
Mesothelioma | 4 | 2023 | 807 | 1.260 |
Why?
|
Neoplasms, Glandular and Epithelial | 3 | 2023 | 487 | 1.250 |
Why?
|
Pathology, Molecular | 6 | 2023 | 328 | 1.110 |
Why?
|
Neoplastic Syndromes, Hereditary | 6 | 2024 | 245 | 1.110 |
Why?
|
Carcinoma, Neuroendocrine | 3 | 2023 | 339 | 1.060 |
Why?
|
Neoplasms | 26 | 2024 | 22173 | 1.040 |
Why?
|
Receptor Protein-Tyrosine Kinases | 8 | 2021 | 1626 | 1.010 |
Why?
|
Humans | 309 | 2024 | 761596 | 0.940 |
Why?
|
Genomics | 25 | 2024 | 5821 | 0.900 |
Why?
|
Endometrial Neoplasms | 6 | 2023 | 1366 | 0.870 |
Why?
|
Oncogene Proteins | 4 | 2018 | 719 | 0.870 |
Why?
|
Carcinoma, Large Cell | 2 | 2014 | 113 | 0.860 |
Why?
|
Transcription Factors | 16 | 2023 | 12130 | 0.830 |
Why?
|
Protein Kinase Inhibitors | 28 | 2024 | 5672 | 0.820 |
Why?
|
Carcinoma, Squamous Cell | 11 | 2021 | 4024 | 0.800 |
Why?
|
Purine-Nucleoside Phosphorylase | 2 | 2022 | 28 | 0.800 |
Why?
|
Proto-Oncogene Proteins | 13 | 2024 | 4514 | 0.790 |
Why?
|
Receptor, trkC | 1 | 2021 | 63 | 0.780 |
Why?
|
Colorectal Neoplasms | 13 | 2024 | 6938 | 0.780 |
Why?
|
Receptor, erbB-2 | 4 | 2023 | 2557 | 0.780 |
Why?
|
Gene Fusion | 3 | 2021 | 356 | 0.770 |
Why?
|
Oncogene Proteins, Fusion | 7 | 2023 | 1609 | 0.750 |
Why?
|
Nuclear Proteins | 15 | 2023 | 5799 | 0.740 |
Why?
|
Protein-Tyrosine Kinases | 9 | 2024 | 2425 | 0.740 |
Why?
|
Mediastinal Diseases | 1 | 2021 | 91 | 0.730 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 3 | 2021 | 698 | 0.720 |
Why?
|
Receptors, Nerve Growth Factor | 1 | 2021 | 198 | 0.720 |
Why?
|
Thymus Hyperplasia | 3 | 2015 | 32 | 0.710 |
Why?
|
Incidental Findings | 3 | 2024 | 697 | 0.710 |
Why?
|
Cytogenetics | 2 | 2021 | 198 | 0.700 |
Why?
|
Aged | 115 | 2024 | 169310 | 0.700 |
Why?
|
Maxillary Sinus Neoplasms | 2 | 2018 | 39 | 0.700 |
Why?
|
Carcinoma | 6 | 2019 | 2330 | 0.700 |
Why?
|
Camptothecin | 1 | 2023 | 591 | 0.690 |
Why?
|
Maxillary Neoplasms | 1 | 2020 | 47 | 0.690 |
Why?
|
Odontogenic Cysts | 1 | 2020 | 42 | 0.690 |
Why?
|
Splenomegaly | 1 | 2020 | 189 | 0.690 |
Why?
|
Odontogenic Tumors | 1 | 2020 | 45 | 0.680 |
Why?
|
Genetic Markers | 3 | 2017 | 2601 | 0.670 |
Why?
|
Middle Aged | 126 | 2024 | 220921 | 0.670 |
Why?
|
Heart Neoplasms | 1 | 2023 | 362 | 0.670 |
Why?
|
Choristoma | 1 | 2021 | 206 | 0.670 |
Why?
|
Sarcoma | 5 | 2022 | 1801 | 0.660 |
Why?
|
Severe Acute Respiratory Syndrome | 1 | 2020 | 137 | 0.650 |
Why?
|
Mandibular Neoplasms | 1 | 2020 | 130 | 0.650 |
Why?
|
Peritoneal Neoplasms | 3 | 2020 | 711 | 0.650 |
Why?
|
SOXB1 Transcription Factors | 2 | 2010 | 286 | 0.610 |
Why?
|
Genes, Neoplasm | 1 | 2020 | 370 | 0.610 |
Why?
|
Pseudolymphoma | 2 | 2015 | 30 | 0.600 |
Why?
|
Female | 146 | 2024 | 392705 | 0.600 |
Why?
|
Soft Tissue Neoplasms | 6 | 2022 | 1159 | 0.590 |
Why?
|
Myeloproliferative Disorders | 2 | 2017 | 613 | 0.590 |
Why?
|
Male | 140 | 2024 | 360846 | 0.590 |
Why?
|
Drug Resistance, Neoplasm | 15 | 2024 | 5305 | 0.580 |
Why?
|
Aged, 80 and over | 52 | 2024 | 58984 | 0.580 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 4 | 2023 | 491 | 0.570 |
Why?
|
Pneumonectomy | 1 | 2024 | 1119 | 0.570 |
Why?
|
Lung | 25 | 2024 | 10002 | 0.570 |
Why?
|
Translocation, Genetic | 5 | 2017 | 1393 | 0.560 |
Why?
|
Karyotyping | 3 | 2016 | 1171 | 0.560 |
Why?
|
Genes, erbB-1 | 3 | 2020 | 162 | 0.560 |
Why?
|
Idiopathic Pulmonary Fibrosis | 5 | 2024 | 515 | 0.550 |
Why?
|
In Situ Hybridization | 5 | 2021 | 1900 | 0.550 |
Why?
|
Plasma Cell Granuloma, Pulmonary | 1 | 2016 | 12 | 0.540 |
Why?
|
Ovarian Neoplasms | 7 | 2023 | 4878 | 0.540 |
Why?
|
Lymphoma, Non-Hodgkin | 2 | 2017 | 1374 | 0.540 |
Why?
|
Thoracic Surgery | 1 | 2023 | 722 | 0.540 |
Why?
|
Adult | 105 | 2024 | 221210 | 0.530 |
Why?
|
Pathology, Clinical | 6 | 2024 | 376 | 0.530 |
Why?
|
Exons | 8 | 2024 | 2391 | 0.520 |
Why?
|
Ubiquitin Thiolesterase | 4 | 2023 | 455 | 0.510 |
Why?
|
Reagent Strips | 1 | 2015 | 39 | 0.490 |
Why?
|
Sequence Analysis, DNA | 10 | 2019 | 4740 | 0.480 |
Why?
|
ras Proteins | 8 | 2020 | 1054 | 0.470 |
Why?
|
Gene Silencing | 2 | 2020 | 1509 | 0.460 |
Why?
|
Proto-Oncogene Proteins B-raf | 8 | 2020 | 2057 | 0.460 |
Why?
|
Colorectal Neoplasms, Hereditary Nonpolyposis | 4 | 2019 | 380 | 0.460 |
Why?
|
Isocitrate Dehydrogenase | 2 | 2018 | 938 | 0.460 |
Why?
|
Early Detection of Cancer | 5 | 2021 | 3201 | 0.450 |
Why?
|
Uterine Neoplasms | 6 | 2022 | 1420 | 0.450 |
Why?
|
Trans-Activators | 2 | 2023 | 2856 | 0.450 |
Why?
|
Immunotherapy | 14 | 2024 | 4652 | 0.450 |
Why?
|
Granulosa Cell Tumor | 3 | 2024 | 77 | 0.440 |
Why?
|
Physician's Role | 1 | 2020 | 917 | 0.430 |
Why?
|
Neoplasm Proteins | 6 | 2018 | 3617 | 0.430 |
Why?
|
Sertoli Cell Tumor | 2 | 2023 | 36 | 0.420 |
Why?
|
Neoplasms, Radiation-Induced | 1 | 2017 | 549 | 0.420 |
Why?
|
Brain Neoplasms | 7 | 2024 | 9032 | 0.410 |
Why?
|
Prognosis | 29 | 2024 | 29629 | 0.400 |
Why?
|
Glomus Tumor | 2 | 2022 | 62 | 0.400 |
Why?
|
Neoplasms, Cystic, Mucinous, and Serous | 3 | 2020 | 194 | 0.380 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 7 | 2023 | 3204 | 0.370 |
Why?
|
Molecular Targeted Therapy | 10 | 2020 | 2811 | 0.360 |
Why?
|
Polymerase Chain Reaction | 5 | 2024 | 6075 | 0.360 |
Why?
|
Microsatellite Instability | 6 | 2023 | 716 | 0.350 |
Why?
|
DNA-Binding Proteins | 5 | 2023 | 9610 | 0.350 |
Why?
|
Tumor Suppressor Protein p53 | 8 | 2022 | 2917 | 0.350 |
Why?
|
Adenosarcoma | 3 | 2021 | 36 | 0.350 |
Why?
|
Genetic Predisposition to Disease | 15 | 2022 | 17904 | 0.350 |
Why?
|
Breast Neoplasms | 5 | 2023 | 21019 | 0.350 |
Why?
|
Antineoplastic Agents | 14 | 2023 | 13642 | 0.350 |
Why?
|
Neurofibromin 2 | 2 | 2022 | 271 | 0.340 |
Why?
|
Adrenal Gland Neoplasms | 1 | 2015 | 732 | 0.330 |
Why?
|
Retrospective Studies | 39 | 2024 | 80647 | 0.330 |
Why?
|
Mediastinal Neoplasms | 1 | 2012 | 401 | 0.330 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2015 | 988 | 0.330 |
Why?
|
Genetic Testing | 7 | 2022 | 3537 | 0.330 |
Why?
|
Neoplastic Cells, Circulating | 1 | 2016 | 946 | 0.330 |
Why?
|
Sensitivity and Specificity | 14 | 2024 | 14665 | 0.320 |
Why?
|
Metaplasia | 2 | 2020 | 322 | 0.320 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2019 | 2898 | 0.320 |
Why?
|
Autopsy | 4 | 2022 | 1009 | 0.320 |
Why?
|
Melanoma | 5 | 2021 | 5709 | 0.310 |
Why?
|
Leukemia | 1 | 2017 | 1522 | 0.310 |
Why?
|
Neoadjuvant Therapy | 6 | 2023 | 2828 | 0.310 |
Why?
|
Head and Neck Neoplasms | 2 | 2020 | 2894 | 0.300 |
Why?
|
Gene Dosage | 3 | 2016 | 1218 | 0.290 |
Why?
|
Neoplasm Staging | 14 | 2022 | 11120 | 0.290 |
Why?
|
Mannose-Binding Lectins | 1 | 2007 | 96 | 0.280 |
Why?
|
Genes, Tumor Suppressor | 2 | 2022 | 1062 | 0.280 |
Why?
|
Young Adult | 32 | 2023 | 59260 | 0.280 |
Why?
|
Membrane Proteins | 9 | 2020 | 7859 | 0.280 |
Why?
|
Diagnosis, Differential | 13 | 2022 | 12973 | 0.270 |
Why?
|
DNA Copy Number Variations | 7 | 2022 | 2020 | 0.270 |
Why?
|
Genes, ras | 3 | 2020 | 654 | 0.270 |
Why?
|
MAP Kinase Kinase 1 | 3 | 2022 | 332 | 0.270 |
Why?
|
Lung Diseases, Interstitial | 3 | 2020 | 918 | 0.270 |
Why?
|
Antigens, CD | 3 | 2018 | 4001 | 0.260 |
Why?
|
Cell Differentiation | 6 | 2020 | 11530 | 0.260 |
Why?
|
Bone Neoplasms | 2 | 2015 | 2529 | 0.260 |
Why?
|
Genital Neoplasms, Female | 2 | 2022 | 532 | 0.260 |
Why?
|
Seminoma | 2 | 2023 | 134 | 0.250 |
Why?
|
Lung Transplantation | 3 | 2023 | 1310 | 0.250 |
Why?
|
Histiocytosis, Langerhans-Cell | 1 | 2007 | 169 | 0.250 |
Why?
|
Colonic Neoplasms | 4 | 2020 | 2539 | 0.250 |
Why?
|
Smoking | 8 | 2022 | 9053 | 0.250 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 4 | 2023 | 1092 | 0.240 |
Why?
|
Tomography, X-Ray Computed | 12 | 2019 | 20568 | 0.240 |
Why?
|
Leukemia Inhibitory Factor | 1 | 2024 | 77 | 0.240 |
Why?
|
Endodermal Sinus Tumor | 2 | 2022 | 53 | 0.240 |
Why?
|
ADAM Proteins | 2 | 2018 | 238 | 0.240 |
Why?
|
Adenoma | 3 | 2021 | 2163 | 0.230 |
Why?
|
Solitary Pulmonary Nodule | 2 | 2018 | 278 | 0.230 |
Why?
|
Pulmonary Artery | 2 | 2024 | 1927 | 0.230 |
Why?
|
Pyridines | 6 | 2021 | 2875 | 0.230 |
Why?
|
Acrylamides | 4 | 2020 | 260 | 0.230 |
Why?
|
DNA Helicases | 5 | 2023 | 851 | 0.230 |
Why?
|
Carcinoma, Adenoid Cystic | 2 | 2017 | 262 | 0.230 |
Why?
|
beta Catenin | 2 | 2022 | 1040 | 0.230 |
Why?
|
Gene Expression | 3 | 2020 | 7581 | 0.230 |
Why?
|
Lung Diseases | 3 | 2017 | 1909 | 0.230 |
Why?
|
Sertoli-Leydig Cell Tumor | 1 | 2023 | 19 | 0.230 |
Why?
|
Immunophenotyping | 4 | 2024 | 1869 | 0.230 |
Why?
|
Lectins, C-Type | 1 | 2007 | 585 | 0.230 |
Why?
|
Phosphatidylinositol 3-Kinases | 5 | 2023 | 2865 | 0.220 |
Why?
|
Biological Products | 2 | 2023 | 914 | 0.220 |
Why?
|
Tumor Suppressor Proteins | 4 | 2022 | 2805 | 0.220 |
Why?
|
Chromosome Aberrations | 6 | 2024 | 1768 | 0.220 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 2 | 2 | 2015 | 214 | 0.220 |
Why?
|
Genotype | 9 | 2021 | 12990 | 0.220 |
Why?
|
Histocytochemistry | 1 | 2024 | 698 | 0.220 |
Why?
|
Mediastinum | 2 | 2021 | 266 | 0.220 |
Why?
|
Carney Complex | 1 | 2023 | 15 | 0.220 |
Why?
|
Practice Guidelines as Topic | 5 | 2020 | 7391 | 0.210 |
Why?
|
Carcinoid Tumor | 2 | 2014 | 224 | 0.210 |
Why?
|
Gene Expression Profiling | 8 | 2021 | 9420 | 0.210 |
Why?
|
Positron-Emission Tomography | 4 | 2015 | 6484 | 0.210 |
Why?
|
Immunity, Cellular | 2 | 2020 | 1560 | 0.210 |
Why?
|
Adaptive Immunity | 2 | 2019 | 726 | 0.210 |
Why?
|
Indazoles | 1 | 2024 | 304 | 0.210 |
Why?
|
Rete Testis | 1 | 2022 | 10 | 0.210 |
Why?
|
Liver Neoplasms | 2 | 2016 | 4317 | 0.210 |
Why?
|
Proto-Oncogene Proteins c-ret | 2 | 2023 | 225 | 0.210 |
Why?
|
Adenocarcinoma, Mucinous | 2 | 2017 | 517 | 0.200 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3086 | 0.200 |
Why?
|
Neoplasms, Connective and Soft Tissue | 1 | 2022 | 34 | 0.200 |
Why?
|
Adenomatoid Tumor | 1 | 2022 | 12 | 0.200 |
Why?
|
Interleukin-13 | 1 | 2024 | 392 | 0.200 |
Why?
|
Neoplasms, Unknown Primary | 1 | 2023 | 101 | 0.200 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3206 | 0.200 |
Why?
|
Oncogene Fusion | 2 | 2021 | 81 | 0.200 |
Why?
|
Rhabdomyoma | 1 | 2022 | 56 | 0.200 |
Why?
|
Observer Variation | 5 | 2020 | 2606 | 0.200 |
Why?
|
Gene Deletion | 2 | 2021 | 2665 | 0.200 |
Why?
|
Genital Neoplasms, Male | 1 | 2022 | 68 | 0.200 |
Why?
|
Phenotype | 10 | 2022 | 16592 | 0.200 |
Why?
|
Medical Oncology | 4 | 2023 | 2321 | 0.200 |
Why?
|
Kidney Neoplasms | 4 | 2022 | 4251 | 0.200 |
Why?
|
Matrix Metalloproteinase 8 | 1 | 2021 | 56 | 0.200 |
Why?
|
Leiomyomatosis | 1 | 2022 | 69 | 0.190 |
Why?
|
Neoplasm Recurrence, Local | 8 | 2023 | 9280 | 0.190 |
Why?
|
Granular Cell Tumor | 1 | 2021 | 48 | 0.190 |
Why?
|
Mice | 25 | 2023 | 81539 | 0.190 |
Why?
|
Leydig Cell Tumor | 1 | 2021 | 28 | 0.190 |
Why?
|
Acetonitriles | 1 | 2021 | 54 | 0.190 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 7 | 2023 | 11742 | 0.190 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2024 | 629 | 0.180 |
Why?
|
Uterine Diseases | 1 | 2021 | 108 | 0.180 |
Why?
|
Pulmonary Surfactants | 1 | 2021 | 162 | 0.180 |
Why?
|
DNA Breaks, Single-Stranded | 1 | 2020 | 24 | 0.180 |
Why?
|
Papilloma | 1 | 2021 | 140 | 0.180 |
Why?
|
ras-GRF1 | 1 | 2020 | 26 | 0.180 |
Why?
|
Neoplasms, Complex and Mixed | 1 | 2020 | 35 | 0.180 |
Why?
|
Carcinoma, Renal Cell | 3 | 2022 | 3165 | 0.180 |
Why?
|
Pelvic Neoplasms | 1 | 2022 | 247 | 0.180 |
Why?
|
Reproducibility of Results | 13 | 2024 | 20100 | 0.170 |
Why?
|
Ventilator-Induced Lung Injury | 1 | 2021 | 120 | 0.170 |
Why?
|
GTP Phosphohydrolases | 4 | 2020 | 517 | 0.170 |
Why?
|
Hemoptysis | 1 | 2021 | 152 | 0.170 |
Why?
|
Receptor, trkA | 2 | 2022 | 159 | 0.170 |
Why?
|
Survival Rate | 9 | 2023 | 12723 | 0.170 |
Why?
|
Antibodies, Monoclonal | 6 | 2018 | 9177 | 0.170 |
Why?
|
NF-E2-Related Factor 2 | 4 | 2024 | 373 | 0.170 |
Why?
|
Polyps | 1 | 2021 | 200 | 0.170 |
Why?
|
Immunoenzyme Techniques | 3 | 2013 | 1704 | 0.170 |
Why?
|
Pyrazoles | 4 | 2022 | 2009 | 0.170 |
Why?
|
Pulmonary Atelectasis | 1 | 2020 | 143 | 0.170 |
Why?
|
Syndecan-2 | 1 | 2019 | 23 | 0.170 |
Why?
|
Hong Kong | 1 | 2019 | 166 | 0.170 |
Why?
|
Predictive Value of Tests | 8 | 2021 | 15266 | 0.170 |
Why?
|
Germ-Line Mutation | 5 | 2023 | 1858 | 0.160 |
Why?
|
Gene Expression Regulation, Neoplastic | 9 | 2020 | 8554 | 0.160 |
Why?
|
Aniline Compounds | 3 | 2020 | 1069 | 0.160 |
Why?
|
Upper Gastrointestinal Tract | 1 | 2019 | 46 | 0.160 |
Why?
|
Synovial Membrane | 1 | 2022 | 532 | 0.160 |
Why?
|
Adenocarcinoma, Papillary | 1 | 2019 | 84 | 0.160 |
Why?
|
Animals | 31 | 2023 | 168475 | 0.160 |
Why?
|
Mullerian Ducts | 2 | 2018 | 203 | 0.160 |
Why?
|
Granuloma | 2 | 2018 | 328 | 0.160 |
Why?
|
Pyrimidines | 4 | 2022 | 3028 | 0.160 |
Why?
|
Point Mutation | 2 | 2022 | 1595 | 0.160 |
Why?
|
Benzamides | 1 | 2024 | 1371 | 0.160 |
Why?
|
Adnexal Diseases | 1 | 2019 | 104 | 0.160 |
Why?
|
Lymphoma, Mantle-Cell | 1 | 2021 | 237 | 0.160 |
Why?
|
Histiocytic Sarcoma | 1 | 2019 | 40 | 0.160 |
Why?
|
Prostatic Neoplasms | 4 | 2022 | 11122 | 0.160 |
Why?
|
Biopsy | 7 | 2021 | 6766 | 0.150 |
Why?
|
Smad4 Protein | 1 | 2019 | 191 | 0.150 |
Why?
|
Fibroblasts | 3 | 2024 | 4142 | 0.150 |
Why?
|
Proteomics | 3 | 2023 | 3848 | 0.150 |
Why?
|
Urethra | 1 | 2020 | 405 | 0.150 |
Why?
|
Pulmonary Embolism | 2 | 2024 | 2567 | 0.150 |
Why?
|
Pattern Recognition, Automated | 1 | 2024 | 997 | 0.150 |
Why?
|
Sarcoidosis, Pulmonary | 1 | 2018 | 45 | 0.150 |
Why?
|
Thyroid Neoplasms | 3 | 2016 | 2332 | 0.150 |
Why?
|
Follow-Up Studies | 12 | 2021 | 39106 | 0.150 |
Why?
|
Anilides | 2 | 2018 | 411 | 0.150 |
Why?
|
Testis | 1 | 2021 | 794 | 0.150 |
Why?
|
Immediate-Early Proteins | 1 | 2020 | 449 | 0.150 |
Why?
|
Gastrointestinal Neoplasms | 2 | 2023 | 954 | 0.150 |
Why?
|
Tumor Microenvironment | 6 | 2023 | 3878 | 0.150 |
Why?
|
Societies, Medical | 7 | 2020 | 3905 | 0.150 |
Why?
|
Data Display | 1 | 2018 | 175 | 0.140 |
Why?
|
Mucous Membrane | 1 | 2021 | 659 | 0.140 |
Why?
|
Prostatic Hyperplasia | 1 | 2021 | 521 | 0.140 |
Why?
|
Pharmacogenetics | 1 | 2021 | 675 | 0.140 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2021 | 592 | 0.140 |
Why?
|
Adolescent | 15 | 2023 | 88326 | 0.140 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 3 | 2020 | 4576 | 0.140 |
Why?
|
Fluorescent Antibody Technique | 2 | 2019 | 2467 | 0.140 |
Why?
|
Formaldehyde | 2 | 2017 | 358 | 0.140 |
Why?
|
Genetic Heterogeneity | 1 | 2020 | 732 | 0.140 |
Why?
|
Treatment Outcome | 19 | 2023 | 64685 | 0.140 |
Why?
|
Pathology | 1 | 2020 | 270 | 0.140 |
Why?
|
Interferons | 1 | 2020 | 706 | 0.140 |
Why?
|
Uterine Cervical Neoplasms | 2 | 2022 | 2020 | 0.140 |
Why?
|
MAP Kinase Signaling System | 3 | 2020 | 1486 | 0.140 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 3 | 2017 | 899 | 0.140 |
Why?
|
Alveolitis, Extrinsic Allergic | 1 | 2017 | 63 | 0.140 |
Why?
|
Pancreatic Neoplasms | 3 | 2023 | 5368 | 0.140 |
Why?
|
Respiratory System | 1 | 2020 | 563 | 0.140 |
Why?
|
Signal Transduction | 11 | 2024 | 23447 | 0.140 |
Why?
|
Disease Models, Animal | 10 | 2023 | 18255 | 0.140 |
Why?
|
Chromogranins | 1 | 2017 | 161 | 0.140 |
Why?
|
Epidemiology | 1 | 2019 | 279 | 0.140 |
Why?
|
Oximes | 1 | 2018 | 303 | 0.140 |
Why?
|
Thoracic Diseases | 1 | 2017 | 99 | 0.130 |
Why?
|
Cell Line, Tumor | 12 | 2021 | 16990 | 0.130 |
Why?
|
Larynx | 1 | 2021 | 492 | 0.130 |
Why?
|
Neurofibromatosis 2 | 1 | 2020 | 385 | 0.130 |
Why?
|
Skin Neoplasms | 4 | 2022 | 5821 | 0.130 |
Why?
|
World Health Organization | 3 | 2021 | 1322 | 0.130 |
Why?
|
Oncogene Proteins v-myb | 1 | 2016 | 25 | 0.130 |
Why?
|
Leukemia, Hairy Cell | 1 | 2016 | 82 | 0.130 |
Why?
|
Airway Obstruction | 1 | 2021 | 661 | 0.130 |
Why?
|
Neurofibromatosis 1 | 1 | 2021 | 561 | 0.130 |
Why?
|
Carcinoma, Transitional Cell | 1 | 2023 | 783 | 0.130 |
Why?
|
Microsatellite Repeats | 1 | 2018 | 784 | 0.130 |
Why?
|
Immunoconjugates | 1 | 2023 | 953 | 0.130 |
Why?
|
Quinoxalines | 1 | 2018 | 296 | 0.130 |
Why?
|
Salivary Gland Neoplasms | 2 | 2017 | 304 | 0.130 |
Why?
|
Prostate | 2 | 2021 | 1773 | 0.130 |
Why?
|
Pneumonia | 3 | 2017 | 2143 | 0.130 |
Why?
|
Mesonephroma | 1 | 2015 | 21 | 0.130 |
Why?
|
NF-kappa B p52 Subunit | 1 | 2015 | 35 | 0.130 |
Why?
|
Nevus, Pigmented | 1 | 2018 | 222 | 0.130 |
Why?
|
Receptors, Notch | 1 | 2020 | 744 | 0.130 |
Why?
|
Dendritic Cell Sarcoma, Follicular | 1 | 2015 | 30 | 0.130 |
Why?
|
GTP-Binding Protein alpha Subunits, Gs | 1 | 2017 | 195 | 0.130 |
Why?
|
Biopsy, Fine-Needle | 2 | 2018 | 1118 | 0.130 |
Why?
|
Bronchiolitis Obliterans | 1 | 2017 | 213 | 0.130 |
Why?
|
DNA Breaks, Double-Stranded | 1 | 2020 | 613 | 0.130 |
Why?
|
Tissue Embedding | 1 | 2015 | 42 | 0.130 |
Why?
|
Carcinoma in Situ | 1 | 2021 | 791 | 0.130 |
Why?
|
Pyrimidinones | 1 | 2018 | 385 | 0.130 |
Why?
|
B-Cell Activating Factor | 1 | 2015 | 115 | 0.120 |
Why?
|
DNA Polymerase II | 1 | 2015 | 104 | 0.120 |
Why?
|
Specimen Handling | 2 | 2021 | 702 | 0.120 |
Why?
|
Cytodiagnosis | 1 | 2019 | 447 | 0.120 |
Why?
|
Janus Kinase 3 | 1 | 2015 | 76 | 0.120 |
Why?
|
Paper | 1 | 2015 | 84 | 0.120 |
Why?
|
Diamines | 1 | 2015 | 60 | 0.120 |
Why?
|
Molecular Diagnostic Techniques | 2 | 2023 | 610 | 0.120 |
Why?
|
Mucins | 2 | 2020 | 568 | 0.120 |
Why?
|
Port-Wine Stain | 1 | 2014 | 33 | 0.120 |
Why?
|
Myofibroma | 1 | 2015 | 45 | 0.120 |
Why?
|
Cell Lineage | 3 | 2018 | 2557 | 0.120 |
Why?
|
Receptor, Notch1 | 1 | 2017 | 496 | 0.120 |
Why?
|
Genes, erbB-2 | 1 | 2015 | 162 | 0.120 |
Why?
|
Melanocytes | 1 | 2018 | 509 | 0.120 |
Why?
|
Kaplan-Meier Estimate | 6 | 2017 | 6484 | 0.120 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2010 | 3615 | 0.120 |
Why?
|
Cryopreservation | 1 | 2020 | 728 | 0.120 |
Why?
|
Endothelium | 1 | 2017 | 765 | 0.120 |
Why?
|
Gene Library | 1 | 2017 | 1059 | 0.120 |
Why?
|
S100 Proteins | 2 | 2022 | 218 | 0.120 |
Why?
|
Prednisone | 1 | 2019 | 1563 | 0.120 |
Why?
|
Neurofibromin 1 | 1 | 2016 | 190 | 0.120 |
Why?
|
Diagnostic Imaging | 3 | 2018 | 3530 | 0.120 |
Why?
|
Pancreas | 1 | 2021 | 1691 | 0.120 |
Why?
|
B-Lymphocytes | 2 | 2019 | 4758 | 0.120 |
Why?
|
Mediastinal Cyst | 1 | 2014 | 29 | 0.120 |
Why?
|
Organic Chemicals | 1 | 2015 | 210 | 0.120 |
Why?
|
Lymphatic Metastasis | 2 | 2023 | 2915 | 0.120 |
Why?
|
Pulmonary Emphysema | 1 | 2019 | 684 | 0.110 |
Why?
|
Facial Dermatoses | 1 | 2014 | 86 | 0.110 |
Why?
|
Biological Specimen Banks | 1 | 2020 | 783 | 0.110 |
Why?
|
Benzothiazoles | 1 | 2015 | 247 | 0.110 |
Why?
|
Urinary Bladder | 1 | 2020 | 1152 | 0.110 |
Why?
|
GTP-Binding Protein alpha Subunits | 1 | 2014 | 102 | 0.110 |
Why?
|
Paraffin Embedding | 2 | 2017 | 302 | 0.110 |
Why?
|
Carcinoma, Basal Cell | 1 | 2019 | 560 | 0.110 |
Why?
|
DNA Repair | 2 | 2020 | 2046 | 0.110 |
Why?
|
Tissue Fixation | 1 | 2015 | 241 | 0.110 |
Why?
|
Lymphoid Tissue | 1 | 2015 | 445 | 0.110 |
Why?
|
Thoracic Neoplasms | 1 | 2016 | 267 | 0.110 |
Why?
|
Epithelial Cells | 3 | 2020 | 3677 | 0.110 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2016 | 718 | 0.110 |
Why?
|
Organoids | 1 | 2020 | 746 | 0.110 |
Why?
|
Succinate Dehydrogenase | 1 | 2014 | 145 | 0.110 |
Why?
|
Teratoma | 1 | 2016 | 404 | 0.110 |
Why?
|
Carcinoma, Merkel Cell | 1 | 2018 | 328 | 0.110 |
Why?
|
Receptor, trkB | 1 | 2014 | 124 | 0.110 |
Why?
|
Mucin-1 | 1 | 2018 | 540 | 0.110 |
Why?
|
Fallopian Tube Neoplasms | 1 | 2016 | 328 | 0.110 |
Why?
|
Acute Disease | 2 | 2017 | 7237 | 0.110 |
Why?
|
Janus Kinase 2 | 2 | 2024 | 560 | 0.110 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2015 | 638 | 0.110 |
Why?
|
Piperazines | 2 | 2021 | 2523 | 0.110 |
Why?
|
Sequence Analysis, RNA | 1 | 2021 | 2021 | 0.110 |
Why?
|
Cohort Studies | 13 | 2023 | 41495 | 0.110 |
Why?
|
Leiomyosarcoma | 1 | 2017 | 422 | 0.110 |
Why?
|
Carcinoma, Papillary, Follicular | 1 | 2013 | 60 | 0.110 |
Why?
|
Tissue Array Analysis | 3 | 2019 | 550 | 0.100 |
Why?
|
Quinazolines | 2 | 2017 | 1371 | 0.100 |
Why?
|
Pyridones | 1 | 2018 | 809 | 0.100 |
Why?
|
RNA, Viral | 1 | 2021 | 2846 | 0.100 |
Why?
|
Immunity, Humoral | 1 | 2016 | 606 | 0.100 |
Why?
|
Nucleic Acids | 1 | 2014 | 188 | 0.100 |
Why?
|
Sulfonamides | 2 | 2020 | 1979 | 0.100 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2023 | 4580 | 0.100 |
Why?
|
Imidazoles | 1 | 2018 | 1180 | 0.100 |
Why?
|
Bronchial Hyperreactivity | 1 | 2013 | 302 | 0.100 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2021 | 2057 | 0.100 |
Why?
|
Mutation, Missense | 2 | 2023 | 2571 | 0.100 |
Why?
|
Patient Selection | 3 | 2019 | 4244 | 0.100 |
Why?
|
Statistics, Nonparametric | 1 | 2017 | 2850 | 0.100 |
Why?
|
Antigens, Neoplasm | 2 | 2016 | 1993 | 0.090 |
Why?
|
Neuroendocrine Tumors | 1 | 2018 | 641 | 0.090 |
Why?
|
Neoplasm Metastasis | 6 | 2019 | 4915 | 0.090 |
Why?
|
Child | 10 | 2023 | 80158 | 0.090 |
Why?
|
Mutant Proteins | 1 | 2013 | 491 | 0.090 |
Why?
|
Boston | 3 | 2019 | 9327 | 0.090 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2012 | 477 | 0.090 |
Why?
|
Tumor Escape | 1 | 2013 | 370 | 0.090 |
Why?
|
Thyroid Gland | 2 | 2016 | 1170 | 0.090 |
Why?
|
Cell Proliferation | 6 | 2019 | 10451 | 0.090 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2023 | 2223 | 0.090 |
Why?
|
Adrenal Cortex Hormones | 1 | 2019 | 1881 | 0.090 |
Why?
|
Respiration, Artificial | 1 | 2021 | 2630 | 0.090 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2021 | 1640 | 0.090 |
Why?
|
Chromosomes | 2 | 2023 | 578 | 0.080 |
Why?
|
Adenocarcinoma, Bronchiolo-Alveolar | 1 | 2009 | 89 | 0.080 |
Why?
|
Meningioma | 1 | 2018 | 1218 | 0.080 |
Why?
|
Quinolines | 1 | 2015 | 765 | 0.080 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2014 | 1171 | 0.080 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2016 | 1784 | 0.080 |
Why?
|
Mice, Transgenic | 2 | 2020 | 9542 | 0.080 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2015 | 2457 | 0.080 |
Why?
|
High-Throughput Screening Assays | 1 | 2015 | 934 | 0.080 |
Why?
|
Toll-Like Receptor 9 | 1 | 2010 | 233 | 0.080 |
Why?
|
Meningeal Neoplasms | 1 | 2018 | 1248 | 0.080 |
Why?
|
Thymus Gland | 1 | 2014 | 1243 | 0.080 |
Why?
|
Aneuploidy | 2 | 2023 | 552 | 0.080 |
Why?
|
Enhancer Elements, Genetic | 1 | 2016 | 1363 | 0.080 |
Why?
|
Artificial Intelligence | 1 | 2023 | 2578 | 0.080 |
Why?
|
Wolffian Ducts | 2 | 2019 | 27 | 0.080 |
Why?
|
Interleukin-4 | 2 | 2024 | 1149 | 0.080 |
Why?
|
Oncogenes | 3 | 2021 | 1222 | 0.080 |
Why?
|
Prevalence | 2 | 2023 | 15733 | 0.080 |
Why?
|
Stomach Neoplasms | 1 | 2019 | 1459 | 0.080 |
Why?
|
Proportional Hazards Models | 4 | 2023 | 12463 | 0.080 |
Why?
|
Receptors, Proteinase-Activated | 1 | 2008 | 19 | 0.080 |
Why?
|
Neoplasm Invasiveness | 3 | 2022 | 3597 | 0.080 |
Why?
|
Ligands | 3 | 2021 | 3272 | 0.080 |
Why?
|
Risk Factors | 10 | 2023 | 74213 | 0.080 |
Why?
|
Receptors, Antigen, T-Cell, gamma-delta | 1 | 2010 | 347 | 0.070 |
Why?
|
Tumor Cells, Cultured | 4 | 2018 | 6131 | 0.070 |
Why?
|
Chromogenic Compounds | 1 | 2007 | 31 | 0.070 |
Why?
|
Cooperative Behavior | 1 | 2015 | 1505 | 0.070 |
Why?
|
T-Lymphocytes | 3 | 2016 | 10194 | 0.070 |
Why?
|
Thrombomodulin | 1 | 2008 | 105 | 0.070 |
Why?
|
Chimera | 1 | 2009 | 453 | 0.070 |
Why?
|
Prospective Studies | 10 | 2023 | 54423 | 0.070 |
Why?
|
Radiography | 2 | 2015 | 6965 | 0.070 |
Why?
|
Immunoglobulin Heavy Chains | 1 | 2010 | 647 | 0.070 |
Why?
|
Discriminant Analysis | 1 | 2007 | 223 | 0.070 |
Why?
|
United States | 10 | 2024 | 72340 | 0.070 |
Why?
|
Lymphoma | 1 | 2016 | 1901 | 0.070 |
Why?
|
Mitosis | 2 | 2023 | 1188 | 0.070 |
Why?
|
Fluorescent Dyes | 1 | 2015 | 1903 | 0.070 |
Why?
|
NF-kappa B | 1 | 2015 | 2490 | 0.070 |
Why?
|
Pathology, Surgical | 2 | 2019 | 151 | 0.070 |
Why?
|
Arthritis, Rheumatoid | 1 | 2022 | 3763 | 0.070 |
Why?
|
Xenograft Model Antitumor Assays | 3 | 2020 | 3605 | 0.070 |
Why?
|
Cell Nucleus | 3 | 2019 | 2910 | 0.070 |
Why?
|
Thiazoles | 1 | 2013 | 1517 | 0.070 |
Why?
|
Promoter Regions, Genetic | 2 | 2016 | 5790 | 0.070 |
Why?
|
Placenta Diseases | 1 | 2008 | 199 | 0.060 |
Why?
|
Cell Line | 5 | 2020 | 15601 | 0.060 |
Why?
|
Neoplasm, Residual | 1 | 2010 | 1008 | 0.060 |
Why?
|
DNA Methylation | 2 | 2017 | 4399 | 0.060 |
Why?
|
Leukemia Inhibitory Factor Receptor alpha Subunit | 1 | 2024 | 30 | 0.060 |
Why?
|
Consensus | 3 | 2021 | 3124 | 0.060 |
Why?
|
American Cancer Society | 1 | 2024 | 69 | 0.060 |
Why?
|
Antigens, CD1 | 1 | 2007 | 439 | 0.060 |
Why?
|
NIH 3T3 Cells | 2 | 2017 | 670 | 0.060 |
Why?
|
Carcinoma, Papillary | 1 | 2009 | 785 | 0.060 |
Why?
|
Feasibility Studies | 3 | 2020 | 5247 | 0.060 |
Why?
|
Mice, Inbred C57BL | 6 | 2021 | 22174 | 0.060 |
Why?
|
Palliative Care | 1 | 2019 | 3598 | 0.060 |
Why?
|
Immunity | 2 | 2020 | 996 | 0.050 |
Why?
|
Membrane Glycoproteins | 1 | 2014 | 3701 | 0.050 |
Why?
|
Ifosfamide | 1 | 2023 | 232 | 0.050 |
Why?
|
Graft Rejection | 1 | 2016 | 4446 | 0.050 |
Why?
|
Myofibroblasts | 1 | 2024 | 223 | 0.050 |
Why?
|
Inflammation | 4 | 2023 | 10774 | 0.050 |
Why?
|
False Positive Reactions | 2 | 2016 | 957 | 0.050 |
Why?
|
Pilot Projects | 3 | 2021 | 8633 | 0.050 |
Why?
|
Synaptophysin | 1 | 2022 | 139 | 0.050 |
Why?
|
SOXD Transcription Factors | 1 | 2022 | 44 | 0.050 |
Why?
|
Chromosomes, Human, Pair 10 | 1 | 2023 | 277 | 0.050 |
Why?
|
Angiogenesis Inhibitors | 1 | 2012 | 2048 | 0.050 |
Why?
|
Cell Movement | 1 | 2014 | 5205 | 0.050 |
Why?
|
Chromosomes, Human, Pair 12 | 1 | 2023 | 430 | 0.050 |
Why?
|
Cell Cycle | 2 | 2022 | 2932 | 0.050 |
Why?
|
Disease Progression | 5 | 2019 | 13510 | 0.050 |
Why?
|
Fumarate Hydratase | 1 | 2022 | 52 | 0.050 |
Why?
|
Mice, SCID | 2 | 2019 | 2626 | 0.050 |
Why?
|
Survival Analysis | 3 | 2019 | 10090 | 0.050 |
Why?
|
Kidney | 1 | 2017 | 7048 | 0.050 |
Why?
|
Genetic Variation | 1 | 2017 | 6567 | 0.050 |
Why?
|
MutS Homolog 2 Protein | 1 | 2022 | 197 | 0.050 |
Why?
|
Ribonuclease III | 1 | 2023 | 279 | 0.050 |
Why?
|
Disease-Free Survival | 3 | 2019 | 6815 | 0.050 |
Why?
|
Up-Regulation | 2 | 2021 | 4125 | 0.050 |
Why?
|
Lung Compliance | 1 | 2021 | 200 | 0.050 |
Why?
|
Sex Factors | 1 | 2015 | 10554 | 0.050 |
Why?
|
Benzoxazoles | 1 | 2022 | 90 | 0.050 |
Why?
|
Calmodulin-Binding Proteins | 1 | 2022 | 233 | 0.050 |
Why?
|
Apoptosis | 4 | 2020 | 9490 | 0.050 |
Why?
|
Sucrose | 1 | 2021 | 158 | 0.050 |
Why?
|
Trophoblastic Neoplasms | 1 | 2020 | 88 | 0.050 |
Why?
|
DEAD-box RNA Helicases | 1 | 2023 | 384 | 0.040 |
Why?
|
Mice, Knockout | 4 | 2021 | 14417 | 0.040 |
Why?
|
DNA Damage | 2 | 2020 | 2449 | 0.040 |
Why?
|
Surface-Active Agents | 1 | 2020 | 150 | 0.040 |
Why?
|
Cell Survival | 2 | 2020 | 5791 | 0.040 |
Why?
|
Pandemics | 1 | 2020 | 8656 | 0.040 |
Why?
|
Biomarkers, Pharmacological | 1 | 2021 | 161 | 0.040 |
Why?
|
Incidence | 2 | 2023 | 21355 | 0.040 |
Why?
|
Thrombosis | 2 | 2017 | 2942 | 0.040 |
Why?
|
Syntenins | 1 | 2019 | 8 | 0.040 |
Why?
|
Lung Volume Measurements | 1 | 2020 | 375 | 0.040 |
Why?
|
Databases, Genetic | 2 | 2017 | 1742 | 0.040 |
Why?
|
Gene Frequency | 2 | 2017 | 3606 | 0.040 |
Why?
|
National Cancer Institute (U.S.) | 1 | 2021 | 297 | 0.040 |
Why?
|
Asia | 1 | 2021 | 619 | 0.040 |
Why?
|
Appendiceal Neoplasms | 1 | 2021 | 155 | 0.040 |
Why?
|
Neurosecretory Systems | 1 | 2020 | 223 | 0.040 |
Why?
|
Aspartic Acid Endopeptidases | 1 | 2020 | 311 | 0.040 |
Why?
|
Clinical Trials, Phase I as Topic | 1 | 2020 | 326 | 0.040 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2017 | 5672 | 0.040 |
Why?
|
Age Factors | 1 | 2016 | 18399 | 0.040 |
Why?
|
Receptors, Prostaglandin | 1 | 2018 | 53 | 0.040 |
Why?
|
Communicable Diseases | 1 | 2007 | 875 | 0.040 |
Why?
|
Amino Acid Substitution | 2 | 2013 | 1739 | 0.040 |
Why?
|
Protein Phosphatase 2 | 1 | 2020 | 231 | 0.040 |
Why?
|
Radiation Pneumonitis | 1 | 2019 | 102 | 0.040 |
Why?
|
Hematoxylin | 1 | 2018 | 60 | 0.040 |
Why?
|
Cytokines | 1 | 2013 | 7396 | 0.040 |
Why?
|
Eosine Yellowish-(YS) | 1 | 2018 | 69 | 0.040 |
Why?
|
Maximum Tolerated Dose | 1 | 2020 | 883 | 0.040 |
Why?
|
Transcription Factor RelA | 1 | 2019 | 254 | 0.040 |
Why?
|
Algorithms | 2 | 2023 | 14033 | 0.040 |
Why?
|
Sheep | 1 | 2020 | 1440 | 0.040 |
Why?
|
Reagent Kits, Diagnostic | 1 | 2019 | 239 | 0.040 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2020 | 641 | 0.040 |
Why?
|
Recurrence | 1 | 2010 | 8466 | 0.040 |
Why?
|
Tablets | 1 | 2018 | 148 | 0.040 |
Why?
|
Carcinoma, Endometrioid | 1 | 2020 | 276 | 0.040 |
Why?
|
Germ Cells | 1 | 2021 | 634 | 0.040 |
Why?
|
Chromatin | 2 | 2022 | 2961 | 0.040 |
Why?
|
Interferon Regulatory Factor-3 | 1 | 2018 | 141 | 0.040 |
Why?
|
Tennessee | 1 | 2017 | 120 | 0.040 |
Why?
|
Blood Platelets | 1 | 2008 | 2479 | 0.040 |
Why?
|
Base Sequence | 2 | 2020 | 12441 | 0.040 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p18 | 1 | 2017 | 53 | 0.040 |
Why?
|
Benchmarking | 1 | 2023 | 1045 | 0.040 |
Why?
|
STAT1 Transcription Factor | 1 | 2018 | 341 | 0.040 |
Why?
|
Pulmonary Veno-Occlusive Disease | 1 | 2017 | 64 | 0.040 |
Why?
|
Proto-Oncogenes | 1 | 2018 | 321 | 0.040 |
Why?
|
Receptors, Leptin | 1 | 2018 | 350 | 0.030 |
Why?
|
Enzyme Activation | 2 | 2015 | 3597 | 0.030 |
Why?
|
Respiratory Sounds | 1 | 2021 | 702 | 0.030 |
Why?
|
Introns | 1 | 2019 | 981 | 0.030 |
Why?
|
Case-Control Studies | 3 | 2021 | 22176 | 0.030 |
Why?
|
Tissue Distribution | 1 | 2020 | 2264 | 0.030 |
Why?
|
Stromal Cells | 1 | 2022 | 1330 | 0.030 |
Why?
|
Drug Synergism | 1 | 2020 | 1757 | 0.030 |
Why?
|
Keratinocytes | 1 | 2020 | 791 | 0.030 |
Why?
|
Protein Tyrosine Phosphatases | 1 | 2018 | 457 | 0.030 |
Why?
|
Mice, 129 Strain | 1 | 2017 | 371 | 0.030 |
Why?
|
Genomic Instability | 1 | 2020 | 709 | 0.030 |
Why?
|
Cystadenocarcinoma, Serous | 1 | 2020 | 478 | 0.030 |
Why?
|
Obesity | 1 | 2018 | 12947 | 0.030 |
Why?
|
Mice, Nude | 2 | 2015 | 3614 | 0.030 |
Why?
|
Time Factors | 2 | 2024 | 39969 | 0.030 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2019 | 632 | 0.030 |
Why?
|
Comparative Genomic Hybridization | 1 | 2017 | 473 | 0.030 |
Why?
|
Congresses as Topic | 1 | 2020 | 803 | 0.030 |
Why?
|
Phosphorylation | 2 | 2017 | 8321 | 0.030 |
Why?
|
Risk Assessment | 2 | 2022 | 23996 | 0.030 |
Why?
|
Receptor, EphA3 | 1 | 2014 | 13 | 0.030 |
Why?
|
Bronchoscopy | 1 | 2021 | 909 | 0.030 |
Why?
|
Genome-Wide Association Study | 1 | 2014 | 12690 | 0.030 |
Why?
|
Genes, myb | 1 | 2014 | 18 | 0.030 |
Why?
|
Trachea | 1 | 2021 | 1089 | 0.030 |
Why?
|
Microtubule-Associated Proteins | 1 | 2020 | 1076 | 0.030 |
Why?
|
Fatal Outcome | 1 | 2020 | 1835 | 0.030 |
Why?
|
Molecular Conformation | 1 | 2016 | 544 | 0.030 |
Why?
|
Pulmonary Medicine | 1 | 2017 | 221 | 0.030 |
Why?
|
Forkhead Transcription Factors | 1 | 2022 | 1616 | 0.030 |
Why?
|
Mast Cells | 1 | 2022 | 1392 | 0.030 |
Why?
|
Mice, Inbred BALB C | 2 | 2014 | 6214 | 0.030 |
Why?
|
Actins | 1 | 2022 | 2050 | 0.030 |
Why?
|
Postoperative Complications | 1 | 2017 | 15633 | 0.030 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2023 | 2547 | 0.030 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2021 | 3810 | 0.030 |
Why?
|
Methylation | 1 | 2017 | 1084 | 0.030 |
Why?
|
Sirolimus | 1 | 2021 | 1533 | 0.030 |
Why?
|
Genetic Engineering | 1 | 2020 | 933 | 0.030 |
Why?
|
Asthma | 1 | 2013 | 6234 | 0.030 |
Why?
|
Sequence Analysis | 1 | 2014 | 240 | 0.030 |
Why?
|
Europe | 1 | 2021 | 3420 | 0.030 |
Why?
|
Diagnostic Errors | 1 | 2021 | 1265 | 0.030 |
Why?
|
Review Literature as Topic | 1 | 2016 | 348 | 0.030 |
Why?
|
Receptor, Platelet-Derived Growth Factor beta | 1 | 2014 | 184 | 0.030 |
Why?
|
Immune System | 1 | 2019 | 796 | 0.030 |
Why?
|
GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2014 | 147 | 0.030 |
Why?
|
Staining and Labeling | 1 | 2018 | 1085 | 0.030 |
Why?
|
Golgi Apparatus | 1 | 2015 | 405 | 0.030 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2017 | 598 | 0.030 |
Why?
|
Precancerous Conditions | 1 | 2020 | 980 | 0.030 |
Why?
|
Hypoxia-Inducible Factor 1 | 1 | 2014 | 193 | 0.030 |
Why?
|
Genome, Human | 2 | 2017 | 4425 | 0.030 |
Why?
|
Protein Conformation | 1 | 2021 | 3968 | 0.030 |
Why?
|
Loss of Heterozygosity | 1 | 2015 | 662 | 0.030 |
Why?
|
Safety | 1 | 2018 | 1149 | 0.030 |
Why?
|
Models, Biological | 2 | 2020 | 9469 | 0.030 |
Why?
|
Bronchoalveolar Lavage Fluid | 1 | 2015 | 755 | 0.030 |
Why?
|
False Negative Reactions | 1 | 2014 | 573 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-raf | 1 | 2013 | 205 | 0.030 |
Why?
|
Teaching | 1 | 2020 | 1170 | 0.030 |
Why?
|
Comprehension | 1 | 2018 | 621 | 0.030 |
Why?
|
Macrophages | 2 | 2020 | 5767 | 0.030 |
Why?
|
Chemokine CXCL12 | 1 | 2014 | 454 | 0.030 |
Why?
|
RNA | 1 | 2022 | 2725 | 0.030 |
Why?
|
Receptors, Immunologic | 1 | 2018 | 1410 | 0.020 |
Why?
|
Glycosylation | 1 | 2015 | 1097 | 0.020 |
Why?
|
Sarcoidosis | 1 | 2017 | 521 | 0.020 |
Why?
|
Phosphoproteins | 1 | 2021 | 2448 | 0.020 |
Why?
|
Cell Cycle Proteins | 1 | 2023 | 3449 | 0.020 |
Why?
|
Repressor Proteins | 1 | 2022 | 2986 | 0.020 |
Why?
|
Viral Load | 1 | 2020 | 3332 | 0.020 |
Why?
|
Hypersensitivity | 1 | 2001 | 1171 | 0.020 |
Why?
|
Codon | 1 | 2013 | 601 | 0.020 |
Why?
|
Intestines | 1 | 2020 | 1910 | 0.020 |
Why?
|
Prostate-Specific Antigen | 1 | 2021 | 2469 | 0.020 |
Why?
|
Antibody Specificity | 1 | 2013 | 1060 | 0.020 |
Why?
|
Infant | 3 | 2023 | 36193 | 0.020 |
Why?
|
Mice, Mutant Strains | 1 | 2014 | 1749 | 0.020 |
Why?
|
Small Molecule Libraries | 1 | 2016 | 733 | 0.020 |
Why?
|
Structure-Activity Relationship | 1 | 2016 | 3076 | 0.020 |
Why?
|
Terminology as Topic | 1 | 2018 | 1530 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 1 | 2021 | 8181 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2014 | 2016 | 0.020 |
Why?
|
Leptin | 1 | 2018 | 1597 | 0.020 |
Why?
|
Fibrosis | 1 | 2017 | 2049 | 0.020 |
Why?
|
Protein Multimerization | 1 | 2015 | 983 | 0.020 |
Why?
|
Mice, Inbred NOD | 1 | 2014 | 1827 | 0.020 |
Why?
|
Genetic Loci | 1 | 2019 | 2632 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2014 | 1612 | 0.020 |
Why?
|
Odds Ratio | 1 | 2022 | 9647 | 0.020 |
Why?
|
Extracellular Matrix | 1 | 2017 | 1726 | 0.020 |
Why?
|
Animals, Genetically Modified | 1 | 2014 | 1561 | 0.020 |
Why?
|
Endoplasmic Reticulum | 1 | 2015 | 1134 | 0.020 |
Why?
|
Homeodomain Proteins | 1 | 2018 | 2418 | 0.020 |
Why?
|
Transplantation, Homologous | 1 | 2017 | 4807 | 0.020 |
Why?
|
Pedigree | 1 | 2016 | 4542 | 0.020 |
Why?
|
Inflammation Mediators | 1 | 2017 | 1886 | 0.020 |
Why?
|
Child, Preschool | 3 | 2018 | 42232 | 0.020 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2018 | 2872 | 0.020 |
Why?
|
Protein Structure, Tertiary | 1 | 2015 | 3792 | 0.020 |
Why?
|
Eosinophils | 1 | 2013 | 950 | 0.020 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2016 | 3514 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2020 | 8527 | 0.020 |
Why?
|
Education, Medical, Continuing | 1 | 2013 | 823 | 0.020 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2019 | 15936 | 0.020 |
Why?
|
Medical Records | 1 | 2013 | 1408 | 0.020 |
Why?
|
Tumor Burden | 1 | 2013 | 1892 | 0.020 |
Why?
|
Molecular Probes | 1 | 2009 | 309 | 0.020 |
Why?
|
Histones | 1 | 2017 | 2580 | 0.020 |
Why?
|
Transforming Growth Factor beta | 1 | 2014 | 1964 | 0.020 |
Why?
|
Biological Assay | 1 | 2009 | 626 | 0.020 |
Why?
|
Models, Molecular | 1 | 2016 | 5439 | 0.020 |
Why?
|
Oxidative Stress | 1 | 2017 | 3113 | 0.020 |
Why?
|
Antibodies | 1 | 2014 | 2418 | 0.020 |
Why?
|
Maternal-Fetal Exchange | 1 | 2008 | 461 | 0.020 |
Why?
|
CpG Islands | 1 | 2010 | 1230 | 0.020 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2017 | 1728 | 0.020 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2010 | 738 | 0.020 |
Why?
|
DNA, Bacterial | 1 | 2010 | 1479 | 0.020 |
Why?
|
Alleles | 1 | 2017 | 6864 | 0.020 |
Why?
|
Rats | 1 | 2021 | 23741 | 0.020 |
Why?
|
Thrombophilia | 1 | 2008 | 305 | 0.020 |
Why?
|
Hemorrhage | 1 | 2017 | 3424 | 0.020 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2018 | 3359 | 0.020 |
Why?
|
Medicare | 1 | 2023 | 6770 | 0.010 |
Why?
|
Sequence Deletion | 1 | 2009 | 1494 | 0.010 |
Why?
|
Graft vs Host Disease | 1 | 2017 | 3029 | 0.010 |
Why?
|
Endothelial Cells | 1 | 2017 | 3549 | 0.010 |
Why?
|
Genetic Association Studies | 1 | 2013 | 2735 | 0.010 |
Why?
|
Hospitals, General | 1 | 2008 | 798 | 0.010 |
Why?
|
DNA, Viral | 1 | 2010 | 2202 | 0.010 |
Why?
|
Electronic Health Records | 1 | 2021 | 4811 | 0.010 |
Why?
|
Rabbits | 1 | 2009 | 4772 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2023 | 26202 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2016 | 12059 | 0.010 |
Why?
|
Lymphocyte Activation | 1 | 2013 | 5485 | 0.010 |
Why?
|
Clinical Competence | 1 | 2018 | 4793 | 0.010 |
Why?
|
Embryo, Mammalian | 1 | 2008 | 1674 | 0.010 |
Why?
|
Blood Coagulation | 1 | 2008 | 1154 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2023 | 26129 | 0.010 |
Why?
|
Hospitalization | 1 | 2021 | 10721 | 0.010 |
Why?
|
Blotting, Western | 1 | 2009 | 5035 | 0.010 |
Why?
|
Concanavalin A | 1 | 2001 | 190 | 0.010 |
Why?
|
Mice, Inbred A | 1 | 2001 | 246 | 0.010 |
Why?
|
Stimulation, Chemical | 1 | 2001 | 306 | 0.010 |
Why?
|
Bone Marrow Transplantation | 1 | 2009 | 2693 | 0.010 |
Why?
|
Transplantation, Heterologous | 1 | 2009 | 2386 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2017 | 14608 | 0.010 |
Why?
|
Mice, Inbred C3H | 1 | 2001 | 915 | 0.010 |
Why?
|
NFATC Transcription Factors | 1 | 2001 | 389 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 2 | 2018 | 36426 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2009 | 5870 | 0.010 |
Why?
|
Polymorphism, Genetic | 1 | 2009 | 4243 | 0.010 |
Why?
|
Macromolecular Substances | 1 | 2001 | 1434 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2015 | 15843 | 0.010 |
Why?
|
Mothers | 1 | 2008 | 2198 | 0.010 |
Why?
|
Immunoglobulin G | 1 | 2009 | 4544 | 0.010 |
Why?
|
Species Specificity | 1 | 2001 | 2414 | 0.010 |
Why?
|
Spleen | 1 | 2001 | 2295 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2001 | 7593 | 0.000 |
Why?
|
Pregnancy | 1 | 2008 | 29890 | 0.000 |
Why?
|
Cells, Cultured | 1 | 2001 | 18966 | 0.000 |
Why?
|
Gene Expression Regulation | 1 | 2001 | 11904 | 0.000 |
Why?
|